Lansing Street Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Lansing Street Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$29.6K	Hold	702	–	–	0.02%	165
2023 Q1	$25K	Hold	702	–	–	0.02%	186
2022 Q4	$25.7K	Hold	702	–	–	0.02%	196
2022 Q3	$33K	Hold	702	–	–	0.03%	153
2022 Q2	$50K	Hold	702	–	–	0.04%	124
2022 Q1	$59K	Buy	+702	New	+$59.4K	0.04%	121

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Lansing Street Advisors's SYNH Position: Q2 2023 in Review

Lansing Street Advisors held its Syneos Health, Inc. Class A Common Stock (SYNH) position steady in Q2 2023 at 702 shares worth $29.6K. The position accounts for 0.02% of the portfolio, ranked #165.

Lansing Street Advisors first reported a position in SYNH in Q1 2022 and has held it in 6 quarters since. The position peaked at $59K in Q1 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Lansing Street Advisors held 702 shares of Syneos Health, Inc. Class A Common Stock worth $29.6K as of Q2 2023.
Lansing Street Advisors left its Syneos Health, Inc. Class A Common Stock share count unchanged in Q2 2023.
Syneos Health, Inc. Class A Common Stock made up 0.02% of Lansing Street Advisors's portfolio in Q2 2023, its #165 holding.
Lansing Street Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2022 and has held it in 6 quarters since.
Lansing Street Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $59K in Q1 2022.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Lansing Street Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.